In the early stage HCC patients, the sensitivity and AUC were 74.5% and 0.83 (95% CI 0.77-0.89) for PIVKA-II and 60.9% and 0.75 (95% CI 0.68-0.81) for AFP. Here, AFP is linked to hepatocellular carcinoma.